Skip to main content

Dr. Vikas K. Singh, MD

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
16
In the NPI registry since
2012
Medicare patients seen, 2024
340

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2012Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    KY license 48037
  • Internal Medicine Physician
    KY license 48037

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
340
Services billed
1,639
Patients’ average age
76
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 40-54 minutes549147
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes15271
Established patient office or other outpatient visit, 30-39 minutes12191
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes9960
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes6463
New patient office or other outpatient visit, 60-74 minutes6262
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or2521
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes1616
Telephone medical discussion with physician, 21-30 minutes1211

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 15 companies reported 44 payments worth $4,589 in total to this clinician.

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 8, 2025Eisai Inc.
Oct 8, 2025
Consulting Fee
Lenvima · Oncology
$2,000
Jun 3, 2025AstraZeneca Pharmaceuticals LP
Jun 3, 2025
Consulting Fee$1,675
Jan 17, 2025Aveo Pharmaceuticals, Inc.
Jan 17, 2025
Education
FOTIVDA · Oncology · in-kind
$20.00

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Kentucky →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $229 in research payments for these studies, mostly to the institutions running them.

  • A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for…
    AstraZeneca UK Limited

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology & Oncology clinicians in Louisville

Sources

NPI registry (CMS NPPES, November 2026; record last updated April 6, 2018), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1124375134. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.